Sol-Gel Technologies Ltd.Sol-Gel Technologies Ltd.Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd.

No trades
See on Supercharts

SLGL fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
SLGL has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company